Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F77RC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,709
Award facts
- Contract value 100% obligated
- $15,709.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 29, 2026, for Contrave ER 8–90 mg tablets (120 count) with a ceiling value of $15,709.08.
Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of April 30, 2026. No set-aside was used for this award.
Quick answers
Who was awarded contract SPE2DR26F77RC?
SPE2DR26F77RC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 29, 2026.
How much is contract SPE2DR26F77RC worth?
The government has obligated $15,709 on SPE2DR26F77RC.
Is contract SPE2DR26F77RC an order under another contract?
Yes. SPE2DR26F77RC is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F77RC competed?
The extent of competition for SPE2DR26F77RC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award